首页> 外文会议>2011 4th International Conference on Biomedical Engineering and Informatics >Quantum dots-based lateral flow strip assay for rapid detection of clenbuterol
【24h】

Quantum dots-based lateral flow strip assay for rapid detection of clenbuterol

机译:基于量子点的侧流试纸法可快速检测盐酸克伦特罗

获取原文

摘要

Illegal addition of clenbuterol hydrochloride (CLB) in meat products causes a wide-ranging outbreak of illness in East Asia in recent years, hence establishment of an effective and easily popularized system for detection of CLB is extremely important. The methods of lateral flow strip assays (LFSAs) are commonly used in the detection of all manners of biomolecules, which can be applied to quantitative or semi-quantitative detection of multiple compounds in a single strip. The labels used in LFSAs are critical for strip sensitivity. Newly developed labeling material quantum dots (QDs), having the advanced properties including size-adjustable, bright fluorescence, strong resistance against photo bleaching, narrow band-edge luminescence and excellent compatibility with biological molecules, is under consideration to replace the conventional labeling vectors in LFSAs. Quantum dots has been predicted to be a robust reporter for LFSAs, showing great promise for sensitivity and of rapidness, steady, high efficiency and convenience. The preliminary studies showed that the detection of CLB with QD-based LFSAs was successful. A QD-labeled monoclonal antibody which has a high affinity to CLB was employed and competitive LFSAs format was used for the assay design, and a rather successful immuno-chromatographic assay model with QDs as reporter was developed for CLB detection. Future directions will involve optimization of the strip assay system, including elimination of non-specific signal, improvement of assay sensitivity and reduction of detection limit.
机译:近年来,在肉制品中非法添加盐酸克仑特罗(CLB)会在东亚引起广泛的疾病暴发,因此,建立有效且易于推广的CLB检测系统极为重要。横向流带分析法(LFSA)通常用于检测所有形式的生物分子,可将其应用于单个带中多种化合物的定量或半定量检测。 LFSA中使用的标签对于条带敏感度至关重要。正在考虑开发具有先进特性的新开发的标记材料量子点(QD),包括尺寸可调,明亮的荧光,对光漂白的强抵抗力,窄带边缘发光以及与生物分子的优异相容性,以取代传统的标记载体。 LFSA。据预测,量子点将成为LFSA的可靠报告者,显示出对灵敏度以及快速,稳定,高效和便利性的巨大希望。初步研究表明,基于QD的LFSA检测CLB是成功的。使用对CLB具有高亲和力的QD标记单克隆抗体,并使用竞争性LFSAs格式进行分析设计,并开发了一种非常成功的以QDs为报告基因的免疫色谱分析模型进行CLB检测。未来的方向将包括优化试纸检测系统,包括消除非特异性信号,提高检测灵敏度和降低检测限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号